ophthalmologytimes1d
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce treatment burden in wet AMD Patients
In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...
Medscape1d
Working With Ophthalmologists to Diagnose and Manage Thyroid Eye Disease
A joint presentation by an endocrinologist and ophthalmologist reviewed best practices for managing thyroid eye disease, ...
New Research Reveals How Our Eyes “Dance” for Clearer Vision
Researchers in Bonn reveal how subtle eye movements and the density of photoreceptors contribute to sharp vision. Our ability to see begins with the light-sensitive photoreceptor cells in our eyes. A ...